NIRSEVIMAB-ALIP for Antiviral prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 137 adverse event reports in the FDA FAERS database where NIRSEVIMAB-ALIP was used for Antiviral prophylaxis.

Most Reported Side Effects for NIRSEVIMAB-ALIP

Side Effect	Reports	%	Deaths	Hosp.
Drug ineffective	173	22.1%	1	127
Respiratory syncytial virus bronchiolitis	135	17.2%	1	72
Bronchiolitis	83	10.6%	0	65
Incorrect dose administered	80	10.2%	0	2
Respiratory syncytial virus infection	76	9.7%	2	54
Pyrexia	54	6.9%	0	29
Cough	45	5.8%	0	25
Respiratory syncytial virus test positive	36	4.6%	1	30
Extra dose administered	30	3.8%	0	0
Product storage error	30	3.8%	0	0
Rash	25	3.2%	0	6
Oxygen therapy	22	2.8%	0	22
Product administered to patient of inappropriate age	20	2.6%	0	0
Respiratory distress	17	2.2%	0	14
Urticaria	17	2.2%	0	4